What condition does a child have if treated with a clotting factor for a nosebleed?

Master Health Science I with our Anatomy, Physiology, and Medical Conditions Test. Use our quizzes and comprehensive explanations to ace your exam!

Multiple Choice

What condition does a child have if treated with a clotting factor for a nosebleed?

Explanation:
A nosebleed treated with a clotting factor points to a deficiency in the blood’s clotting system. Hemophilia is a genetic disorder where the body lacks one of the clotting factors, most commonly factor VIII or factor IX. When the missing factor is replaced, the coagulation cascade can proceed to form a proper clot and stop the bleeding. This direct factor replacement is a hallmark approach for hemophilia during bleeds. Others like von Willebrand disease involve issues with von Willebrand factor and can also require specialized treatments (such as vWF-containing products or desmopressin in some cases), but the classic scenario of needing a specific clotting factor to halt a bleed is most characteristic of hemophilia. Conditions like anemia or leukemia affect blood cells rather than a single coagulation factor, so they aren’t treated with a clotting factor infusion to stop a nosebleed.

A nosebleed treated with a clotting factor points to a deficiency in the blood’s clotting system. Hemophilia is a genetic disorder where the body lacks one of the clotting factors, most commonly factor VIII or factor IX. When the missing factor is replaced, the coagulation cascade can proceed to form a proper clot and stop the bleeding. This direct factor replacement is a hallmark approach for hemophilia during bleeds.

Others like von Willebrand disease involve issues with von Willebrand factor and can also require specialized treatments (such as vWF-containing products or desmopressin in some cases), but the classic scenario of needing a specific clotting factor to halt a bleed is most characteristic of hemophilia. Conditions like anemia or leukemia affect blood cells rather than a single coagulation factor, so they aren’t treated with a clotting factor infusion to stop a nosebleed.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy